In Care and Cure Chapter 7, Jacob Stegenga discusses a variety of different biases that plague medical research. Collectively these biases make medical interventions appear more effective than they actually are. However, medical research studies are also designed so as to counteract these sources of bias.

Describe three types of bias in medical research discussed by Stegenga as well as how medical research is designed so as to counteract or mitigate that bias (4 points). In your view, which bias impacts medical research the most and why (1 point)? Do issues related to bias in medical research suggest that people should have less confidence in the effectiveness of medical interventions than they currently do? Why or why not (2 points)?

Question

In Care and Cure Chapter 7, Jacob Stegenga discusses a variety of different biases that plague medical research. Collectively these biases make medical interventions appear more effective than they actually are. However, medical research studies are also designed so as to counteract these sources of bias.

Describe three types of bias in medical research discussed by Stegenga as well as how medical research is designed so as to counteract or mitigate that bias (4 points). In your view, which bias impacts medical research the most and why (1 point)? Do issues related to bias in medical research suggest that people should have less confidence in the effectiveness of medical interventions than they currently do? Why or why not (2 points)?

BlackTom AI · Accepted Answer

The question invites a descriptive account of three biases Stegenga identifies in medical research, plus how the research design counters them, an opinion on which bias is most impactful, and a normative judgment about confidence in medical interventions. To satisfy this, we can structure the analysis around core biases, their countermeasures, and then address the evaluative questions.

First, consider publication bias. This occurs when studies with positive or significant results are more likely to be published than those with negative or null results. The consequence is an inflated view of effectiveness because the available literature is not representative of all conducted research. Countermeasures include pre-registration of trials, which commits researchers to reporting planned outcomes, and policies requiring publication of all results or at least full disclosure in registries and journals. These steps promote transparency and reduce selective reporting of favorable findings.

Next, examine selection bias in study participants. If researchers recruit a non-representative sample, the results may not generalize to the broader patient population. A standard remedy is the randomized controlled trial (RCT) design, which uses random allocation to balance known and unknown confounders across groups, increasing comparability and external relevance when conducted properly. Additional mitigations include explicit inclusion/exclusion criteria and intention-to-treat analyses to preserve randomization benefits.

Third, look at outcome reporting bias. This bias arises when researchers highlight favorable outcomes while downplaying or omitting unfavorable or unremarkable results. Mitigation relies on predefined primary and secondary outcomes declared in advance (trial registration) and adherence to established reporting guidelines such as CONSORT, which require comprehensive reporting of all prespecified outcomes and methodological details. These practices reduce selective emphasis on favorable endpoints and improve interpretability.

Now reflect on which bias might have the largest overall impact. One could argue that publication bias often exerts a dominant influence because it shapes the visible evidence base that meta-analyses and clinicians rely upon; if a substantial portion of negative or null results never reaches public view, the apparent effectiveness of interventions can be systematically overestimated regardless of study quality. However, it is important to acknowledge that selection bias and outcome reporting bias also substantially distort findings, especially when trials are small, poorly designed, or selectively reported. The relative weight of each bias may vary by context and field, but publication bias is frequently highlighted as a primary driver of distorted cumulative evidence.

Turning to the broader question of whether biases justify reduced confidence in medical interventions: the presence of biases does not automatically justify wholesale distrust of interventions, but it does warrant heightened scrutiny, transparency, and methodological rigor. A truthful stance is that medical research should be interpreted with consideration of potential biases and with reliance on robust bodies of evidence that incorporate safeguards such as preregistration, randomization, adequate sample sizes, replication, and comprehensive reporting. In other words, confidence should be calibrated to reflect the strength and quality of the evidence, not to downplay the potential for bias any more than is warranted by the data and methods used. The goal is tempered, evidence-based confidence guided by methodological safeguards and ongoing critical appraisal.

类似问题

You own a bond that pays $64 in interest annually. The face value is $1,000 and the current market price is $1,021.61. The bond matures in 11 years. What is the yield to maturity?

Which of the following statements is CORRECT?

It will cost $9,600 to acquire an ice cream cart that is expected to produce cash inflows of $3,600 a year for three years. After the three years, the cart is expected to be worthless. What is the payback period?

A 3.25 percent Treasury bond is quoted at a price of 99.04. The bond pays interest semiannually. What is the current yield?

更多留学生实用工具

智能学习助手

风格化写作助手

论文查重助手

文献引用助手

课堂转译助手

课堂笔记助手

Quiz搜索助手

学校历年真题

智能刷题助手

智能匹配练习

希望你的学习变得更简单